Edition:
United Kingdom

Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

2.04USD
8:00pm BST
Change (% chg)

$-0.02 (-0.97%)
Prev Close
$2.06
Open
$2.09
Day's High
$2.10
Day's Low
$2.01
Volume
77,005
Avg. Vol
175,150
52-wk High
$3.08
52-wk Low
$1.29

Latest Key Developments (Source: Significant Developments)

Athersys And Healios Extend By One Month The Period To Complete Collaboration Expansion Agreements
Tuesday, 1 May 2018 

May 1 (Reuters) - Healios KK <4593.T>::ATHERSYS AND HEALIOS EXTEND BY ONE MONTH THE PERIOD TO COMPLETE COLLABORATION EXPANSION AGREEMENTS.ATHERSYS INC - CO, HEALIOS K.K. AGREED TO EXTEND PERIOD FROM APRIL 30, 2018 TO MAY 31, 2018.  Full Article

Athersys reports Q3 loss per share $0.06
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Athersys Inc :Athersys reports third quarter 2017 results.Q3 loss per share $0.06.Q3 revenue $400,000 versus $300,000.Q3 revenue view $598,000 -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S.  Full Article

Athersys and Nikon Cell Innovation to collaborate on MultiStem manufacturing in Japan
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Athersys Inc ::Athersys and Nikon Cell Innovation to collaborate on multistem commercial manufacturing in Japan.Athersys - entered manufacturing services agreement with Nikon Cell for commercial production of its stem cell therapy in Japan for ischemic stroke.Athersys - technology transfer of stem cell production methods in preparation for potential commercialization in Japan after treasure clinical study.  Full Article

Athersys, FDA agree on design for ischemic stroke late-stage study
Wednesday, 28 Sep 2016 

Athersys Inc :Athersys receives FDA agreement under special protocol assessment for phase 3 study of multistem® treatment for ischemic stroke.  Full Article

Athersys qtrly loss per share $0.08
Tuesday, 9 Aug 2016 

Athersys Inc : Athersys reports second quarter 2016 results . Q2 revenue $600,000 versus $200,000 .Qtrly loss per share $0.08.  Full Article

BRIEF-Athersys And Healios Extend By One Month The Period To Complete Collaboration Expansion Agreements

* ATHERSYS AND HEALIOS EXTEND BY ONE MONTH THE PERIOD TO COMPLETE COLLABORATION EXPANSION AGREEMENTS